These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16401719)

  • 61. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
    Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
    Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High performance liquid chromatographic determination of thalidomide in patients affected by hepatocellular carcinoma.
    Saccomanni G; Turini V; Manera C; Placanica G; Salè EO; Jemos C; Giorgi M; Macchia M
    J Pharm Biomed Anal; 2008 Sep; 48(2):447-51. PubMed ID: 18282676
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
    Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
    Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Second-line thalidomide/IL-2 therapy in metastatic kidney cancer--results of a pilot study].
    Schrader AJ; Heidenreich A; Hegele A; Olbert P; Varga Z; Hofmann R
    Aktuelle Urol; 2006 Nov; 37(6):429-35; quiz 423-4. PubMed ID: 17099831
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Primary carcinoma of the liver and the hypoglycemic syndrome].
    Chlumský J; Krtek V; Chlumská A; Vojtísek V; Hrabal P
    Cas Lek Cesk; 1984 Feb; 123(7):192-5. PubMed ID: 6321027
    [No Abstract]   [Full Text] [Related]  

  • 67. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma.
    Altundag O; Altundag K; Turen S; Gunduz E; Atik MA
    Med Hypotheses; 2006; 66(6):1257. PubMed ID: 16154711
    [No Abstract]   [Full Text] [Related]  

  • 70. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 71. Thalidomide-induced amenorrhea: case report and literature review.
    Dharia SP; Steinkampf MP; Cater C
    Fertil Steril; 2004 Aug; 82(2):460-2. PubMed ID: 15302302
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fatal tumor lysis syndrome and gastric hemorrhage associated with metastatic small-cell lung carcinoma.
    Marinella MA
    Med Pediatr Oncol; 1999 Jun; 32(6):464-5. PubMed ID: 10358713
    [No Abstract]   [Full Text] [Related]  

  • 73. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The effect of etoposide (Et) on primary hepatocellular carcinoma].
    Tanaka N; Furusawa A; Shimoda A; Hirai N; Unoura M; Kato Y; Kobayashi K; Izumi R; Matsui O; Hattori N
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2583-5. PubMed ID: 3039924
    [No Abstract]   [Full Text] [Related]  

  • 75. Hepatocellular carcinoma in arteriohepatic dysplasia.
    Keeffe EB; Pinson CW; Ragsdale J; Zonana J
    Am J Gastroenterol; 1993 Sep; 88(9):1446-9. PubMed ID: 8395765
    [No Abstract]   [Full Text] [Related]  

  • 76. [Paraneoplastic hypereosinophilia associated with hepatocellular carcinoma].
    Bonaventure C; Etienne-Mastroianni B; Alessio A; Scoazec JY; Boillot O; Dumortier J
    Gastroenterol Clin Biol; 2003 Dec; 27(12):1167-9. PubMed ID: 14770124
    [No Abstract]   [Full Text] [Related]  

  • 77. [Chemosensitivity of fibrolamellar carcinoma of the liver].
    Feidt P; Legendre C; Levy VG
    Gastroenterol Clin Biol; 1988 Oct; 12(10):767-8. PubMed ID: 2851475
    [No Abstract]   [Full Text] [Related]  

  • 78. Indomethacin therapy in symptomatic hepatic neoplasms.
    Romeu J; Chadha N; Fukilman O; Dave P; Lee M
    Am J Gastroenterol; 1982 Sep; 77(9):655-9. PubMed ID: 6180633
    [No Abstract]   [Full Text] [Related]  

  • 79. Tumor lysis syndrome and acute renal failure--an increasing spectrum of presentations.
    Mukherjee E; Mukherji D; Jayawardene SA; Kon SP
    Clin Nephrol; 2007 Sep; 68(3):186-9. PubMed ID: 17915624
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vinblastine in the treatment of carcinoma of liver.
    Damrongsak C; Viranuvatti V; Cheranai O; Tuchinda S
    J Med Assoc Thai; 1973 Jun; 56(6):370-2. PubMed ID: 4361658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.